Lung Cancer (cont.)
American Cancer Society (2009). Cancer Facts and Figures 2009. Atlanta: American Cancer Society. Available online: http://www.cancer.org/acs/groups/content/@nho/documents/document/500809webpdf.pdf.
Ettinger DS (2008). Lung cancer and other pulmonary neoplasms. In L Goldman, D Ausiello, eds., Cecil Medicine, 23rd ed., pp. 1456–1465. Philadelphia: Saunders Elsevier.
Rivera MP (2009). Lung cancer in women: The difference in epidemiology, biology and treatment outcomes. Expert Review of Respiratory Medicine, 3(6): 627–634.
National Toxicology Program, U.S. Department of Health and Human Services (2005). Report on Carcinogens, 11th ed. Available online: http://ntp-server.niehs.nih.gov/ntp/roc/toc11.html.
National Comprehensive Cancer Network (2010). Non–Small Cell Lung Cancer, version 2.2010. Available online: http://www.nccn.org/professionals/physician_gls/f_guidelines.asp.
Aldington S, et al. (2008). Cannabis use and risk of lung cancer: A case-control study. European Respiratory Journal, 31(2): 280–286.
Fox JL, et al. (2004). The effect of smoking status on survival following radiation therapy for non–small cell lung cancer. Lung Cancer, 44(3): 287–293.
Dasgupta P, et al. (2006). Nicotine inhibits apoptosis induced by chemotherapeutic drugs by up-regulating XIAP and survivin. Proceedings of the National Academy of Sciences, 103(16): 6332–6337.
Cassileth BR, et al. (2007). Complementary therapies and integrative oncology in lung cancer. Chest, 132: 340S–354S.
Temel JS, et al. (2010). Early palliative care for patients with metastatic non–small-cell lung cancer. New England Journal of Medicine, 363(8): 733–742.
Crawford J (2007). Lung cancer. In DC Dale, DD Federman, eds., ACP Medicine, section 12, chap. 8. New York: WebMD.
Godtfredsen NS, et al. (2005). Effect of smoking reduction on lung cancer risk. JAMA, 294(12): 1505–1510.
Goodman GE, et al. (2004). The beta-carotene and retinol efficacy trial: Incidence of lung cancer and cardiovascular disease mortality during 6-year follow-up after stopping beta-carotene and retinol supplements. Journal of the National Cancer Institute, 96(23): 1743–1750.
Other Works Consulted
Abramowicz M (2003). Treatment guidelines: Drugs of choice for cancer. Medical Letter on Drugs and Therapeutics, 1(7): 41–52.
Detterbeck FC, et al. (2009). Special feature: The new lung cancer staging system. Chest, 136: 260–271.
Erlotinib (Tarceva) for advanced non–small cell lung cancer (2005). Medical Letter on Drugs and Therapeutics, 47(1205): 25–27.
National Cancer Institute (2009). Small Cell Lung Cancer PDQ: Treatment – Patient Version. Available online: http://www.cancer.gov/cancertopics/pdq/treatment/small-cell-lung/Patient.
National Cancer Institute (2010). Non-Small Cell Lung Cancer PDQ: Treatment – Health Professional Version. Available online: http://www.cancer.gov/cancertopics/pdq/treatment/non-small-cell-lung/healthprofessional/HealthProfessional.
National Cancer Institute (2010). Non-Small Cell Lung Cancer PDQ: Treatment – Patient Version. Available online: http://www.cancer.gov/cancertopics/pdq/treatment/non-small-cell-lung/patient.
National Cancer Institute (2010). Small Cell Lung Cancer PDQ: Treatment – Health Professional Version. Available online: http://www.cancer.gov/cancertopics/pdq/treatment/small-cell-lung/HealthProfessional.
Neville A (2009). Lung cancer, search date May 2008. Online version of BMJ Clinical Evidence: http://www.clinicalevidence.com.
Pemetrexed (Alimta) for mesothelioma (2004). Medical Letter on Drugs and Therpeutics, 46(1180): 31–32.
Schwartz DA (2007). Occupational and environmental lung disease. In DC Dale, DD Federman, eds., ACP Medicine, section 14, chapter 18. New York: WebMD.
eMedicineHealth Medical Reference from Healthwise
To learn more visit Healthwise.org
© 1995-2012 Healthwise, Incorporated. Healthwise, Healthwise for every health decision, and the Healthwise logo are trademarks of Healthwise, Incorporated.